Likewise, in our in vivo model, the finding suggested that if the in vivo levels of SPARC are low, the expression of MMP-2/9 and p-ERK would be downregulated to suppress the formation and development of ectopic HCC cell tumor, thereby inhibiting the proliferation of the tumor (Figure 3). Here, MMP2 is linked to neoplasm.